New COVID-19 case numbers for the U.S. overall are still decreasing, according to the CDC’s data. But the drop from the previous week’s cases to this week’s cases (about 5%) is lower than any week-over-week change since Omicron peaked in January, suggesting that we’re heading for a plateau—if not a new increase.
Read More
National COVID-19 case numbers are still falling, as we reach two months since the peak of the Omicron surge. The U.S. reported about 30,000 new cases each day last week, according to the CDC; that’s the lowest this number has been since last summer.
Read More
Overall, new COVID-19 cases are continuing to fall across the U.S. The country reported about 37,000 new cases a day last week, according to the CDC, compared to ten times that number in early February.
Read More
New COVID-19 cases continue falling in the U.S. as the Omicron wave fizzles out. This week, the CDC reported an average of 53,000 new cases a day—less than one-tenth the cases reported at the peak of this surge.
Read More
After several weeks of declines, our national count of new cases has started creeping up: the current 7-day average is 57,000, after 53,000 last week and 55,000 the week before. Michigan continues to see concerning numbers, as do New York, New Jersey, Florida, Texas, and California—all states with higher counts of reported variant cases.
Read More
Our current phase of the pandemic may be described as a race between vaccinations and the spread of variants. Right now, it’s not clear who’s winning. Despite our current vaccination pace, the U.S. reported only 10,000 fewer new cases this week than in the week prior—and rates in some states are rising.
Read More
The U.S. is now vaccinating about 2.5 million people per day. One in four adults has received at least their first shot. And we crossed the 100-million dose mark on Friday, far earlier than President Biden’s 100-day goal. Meanwhile, cases, deaths, and hospitalizations continue to decline.
Read More
More than two million Americans are now getting a dose each day, per Bloomberg, with the first Johnson & Johnson shots landing on the market this week. After the announcement of a cross-pharma partnership (Merck giving J&J a manufacturing boost), President Biden said that the U.S. will have enough COVID-19 vaccine doses for every adult by the end of May.
Read More